------------------------------------------------
Charles A. Nicolette, Ph.D.
Chief Scientific Officer
Vice President, Research and Development
Argos Therapeutics
Biography:
Charles Nicolette is the Vice President of Research and Development at Argos Therapeutics, a biotechnology company focused on the development and commercialization of RNA-transfected dendritic cell-based vaccines for the treatment of cancer and infectious diseases. He is an expert in cellular immunology with extensive experience with dendritic cells and is the inventor on dozens of patent applications in the field. .
He was formerly the Director of Antigen Discovery at Genzyme Molecular Oncology where he developed several new vaccine-related technologies. Charles received his Ph.D. in biochemistry and cellular and developmental biology from the State University of New York at Stony Brook, completing his doctoral dissertation and post-doctoral fellowship at Cold Spring Harbor Laboratory.
